Open Targets Platform Open Targets Platform: release 19.11 is out We have a new release of the Open Targets Platform: new EFO3, FDA pharmacovigilance data, new chemical probes, more targets, more evidence and associations.
Open Targets Platform From antibody to zinc finger: an A-Z of Open Targets As scientists discover our freely available resources, it’s time to take a closer look at the terms that matter to Open Targets. November is time for H.
Open Targets Platform Open Targets Platform: release 19.09 is out We have a new release of the Open Targets Platform: more target-disease associations, more chemical probes and target enabling packages, and updated Elasticsearch.
Open Targets From antibody to zinc finger: an A-Z of Open Targets As users discover our freely available resources, it’s time to take a closer look at the terms that matter to Open Targets. This time we have a double bill: F and G.
Open Targets Platform Open Targets Platform: release 19.06 is out We have a new release of the Open Targets Platform: more target safety information and new target-disease associations are some of the highlights in release 19.06.
Q&A Using CRISPR priority score to identify targets in cancer drug discovery Open Targets Q&A on the first set of CRISPR screen results in cancer for target identification and prioritisation in drug discovery.
Open Targets Platform Open Targets Platform: release 19.04 is out We have a new release of the Open Targets Platform: CRISPR-Cas9 data and target safety information are some of the highlights in release 19.04.
Open Targets From antibody to zinc finger: an A-Z of Open Targets As users discover our freely available resources, it’s time to take a closer look at the terms that matter to Open Targets. March is time for E.
Open Targets Platform Open Targets Platform: release 19.02 is out Our latest release of the Open Targets Platform is out. We have more targets, more diseases, more evidence, more associations, and fixed some bugs too.
Open Targets Platform From antibody to zinc finger: an A-Z of Open Targets As users discover our freely available resources, it’s time to take a closer look at the terms that matter to Open Targets. It's D-time.
Open Targets Platform Open Targets Platform: new release is out The latest release of the Open Targets Platform is out. We have more evidence, new targets, new diseases and new associations, plus data from Probe Miner.
Open Targets Platform Get to know the Reactome enhanced pathway visualisations Open Targets Q&A on the new Reactome pathway visualisations: scalable, interactive textbook-style diagrams in SVG format, freely downloadable and editable.
Europe PMC How Europe PMC can help you find associations between genes and diseases Open Targets Q&A on how you can stay up-to-date with the latest advances in drug discovery.
release notes The latest release of the Open Targets Platform is out! We have a new release of the Open Targets Platform. New data source for target-disease associations, new drug visualisations, cancer biomarkers, and more.
Open Targets Touring with Takeda Following Takeda joining Open Targets in December 2017, I set off to Takeda in the US and Japan for a series of workshops.
Open Targets Open Targets Platform: we have a new release The latest release of Open Targets Platform is out. We now have the cancer hallmarks, targeted association studies, a YouTube channel and much more.
release notes Open Targets Platform: our December release is out! The latest release of Open Targets Platform is out. We now have a dedicated page for drugs, mouse phenotypes mapped to human targets, and more cancer genes.
release notes Open Targets Platform: our latest release is out! We have just released the latest Open Targets Platform, release 17.09. Let's crunch some of the numbers before moving on to our highlights: targets diseases evidence associations 19,803 9,341 6,
Open Targets Platform What is new in the latest release of the Open Targets Platform? The latest version of our Open Targets Platform is out. We have more diseases, more evidence, more associations, more data sources, but fewer targets. If you wonder what and why, keep reading. Let's
Open Targets Translation, Translation, Translation Over the last 14 days, we have had two scientific meetings taking place right here on the Wellcome Genome Campus, the Translational Bioinformatics conference and the Translational Target Validation symposium. What did they
targetvalidation.org Breaking news: extra data in our Open Targets Platform! We have released our latest version of the Open Targets Platform with new and updated data. This is our 17.04 data release. Wonder what are the highlights? In a nutshell: more targets,
Open Targets Platform How to access Open Targets with a list of targets and no programmatic skills You may have read our post on how to Get an association table for your list of genes using the REST API. And thought: "I wish I could search for my list
targetvalidation.org Our latest release is out: it's all about data The latest release of our Open Targets Platform is out. Are you looking for more targets, more diseases, more evidence, more associations, or perhaps all of the above? If you said yes, the
Open Targets Open Targets - First Impressions I recently joined the Open Targets Consortium as Operations Director. This moved me from almost the very end of the R&D pipeline where I had been working on processes for small
targetvalidation.org Did you see the latest version of Open Targets Platform? That's right. The Open Targets Platform v1.2 is out! In this release, we have new web displays and plenty of extra data to assist you in drug discovery and validation: 30,591
